Oklo (NYSE:OKLO) Trading 14.7% Higher - Should You Buy?

Key Points

• Oklo shares surged 14.7% to $48.38 on heavy trading after the company reported $1.21 million in second-quarter revenue, far above the approximately $90,000 analyst estimate.
• The company achieved first criticality at its Groves reactor, enabling initial isotope-production testing, while its roughly $2.5 billion in cash and marketable securities provides funding for continued development.
• Despite a consensus “Moderate Buy” rating and $88 average price target, Oklo remains unprofitable, posted a wider-than-expected $0.28-per-share loss, and faces significant licensing, construction, commercialization and insider-selling risks.

Shares of Oklo Inc. (NYSE:OKLO - Get Free Report) traded up 14.7% during trading on Friday . The stock traded as high as $49.48 and last traded at $48.3790. Approximately 20,911,431 shares were traded during mid-day trading, an increase of 81% from the average session volume of 11,547,461 shares. The stock had previously closed at $42.19.

Key Headlines Impacting Oklo

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: Revenue substantially exceeded expectations. Oklo reported $1.21 million in second-quarter revenue, compared with analysts’ estimate of roughly $90,000. Although the figure remains small, it represents the company’s first meaningful quarterly revenue and contributed to the favorable market reaction. Oklo stock rises as first-ever revenue tops estimates despite wider Q2 loss
• Positive Sentiment: Groves reactor reached first criticality. Oklo’s Groves Isotope Test Reactor in Texas achieved a controlled, self-sustaining nuclear chain reaction at low power less than a year after groundbreaking. The DOE-authorized milestone enables initial isotope-production testing and supports the company’s broader ambitions to supply power to data centers and other customers. Oklo’s Groves Reactor Achieves First Criticality
• Positive Sentiment: Large cash reserves provide development runway. Analysts highlighted Oklo’s approximately $2.5 billion in cash and marketable securities as a funding cushion for licensing, construction and technology development before commercial operations begin. Oklo earnings preview
• Neutral Sentiment: Investors remain focused on the long-term commercialization timeline. Market commentary was cautiously positive, but revenue generation from commercial reactor projects is generally expected in 2027–2028, leaving valuation dependent on successful licensing, construction and customer execution. Analysts’ reported price targets vary widely, reflecting substantial uncertainty.
• Negative Sentiment: Quarterly losses were wider than expected. Oklo posted a loss of $0.28 per share, missing the consensus estimate of a $0.16 loss, as development spending continued. The company remains unprofitable, and analysts expect another full-year loss. Oklo quarterly earnings report
• Negative Sentiment: Insider selling and execution risks remain overhangs. Reported insider activity showed 103 open-market sales and no purchases during the past six months. Oklo also faces regulatory, construction and commercialization risks, while its stock remains well below its 52-week high.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on OKLO. Guggenheim began coverage on shares of Oklo in a research report on Thursday, June 25th. They issued a "neutral" rating for the company. Tigress Financial initiated coverage on Oklo in a research note on Monday, April 27th. They issued a "buy" rating and a $130.00 target price on the stock. Barclays reduced their target price on Oklo from $82.00 to $76.00 and set an "overweight" rating for the company in a report on Wednesday, July 22nd. Bank of America assumed coverage on Oklo in a research report on Friday, May 22nd. They set a "buy" rating and a $80.00 price target for the company. Finally, UBS Group dropped their price target on Oklo from $60.00 to $55.00 and set a "neutral" rating on the stock in a report on Thursday, June 11th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $88.00.

Oklo Trading Up 14.7%

The stock's 50-day moving average price is $51.25 and its two-hundred day moving average price is $60.67. The stock has a market capitalization of $8.42 billion, a P/E ratio of -57.59 and a beta of 1.17.

Oklo (NYSE:OKLO - Get Free Report) last posted its quarterly earnings data on Friday, August 7th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.12). The company had revenue of $1.21 million during the quarter, compared to analyst estimates of $0.09 million. During the same quarter last year, the firm posted ($0.18) EPS. The company's revenue was up 11900.0% compared to the same quarter last year. On average, equities research analysts predict that Oklo Inc. will post -0.74 earnings per share for the current year.

Insider Transactions at Oklo

In other news, CEO Jacob Dewitte sold 140,000 shares of Oklo stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $68.29, for a total value of $9,560,600.00. Following the completion of the transaction, the chief executive officer owned 538,039 shares in the company, valued at $36,742,683.31. This trade represents a 20.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Richard Craig Bealmear sold 73,081 shares of the business's stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $68.42, for a total transaction of $5,000,202.02. Following the completion of the sale, the chief financial officer directly owned 397,642 shares in the company, valued at approximately $27,206,665.64. This trade represents a 15.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 483,629 shares of company stock worth $29,855,608. 12.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Oklo

A number of hedge funds and other institutional investors have recently bought and sold shares of OKLO. State Street Corp boosted its stake in Oklo by 454.5% in the 2nd quarter. State Street Corp now owns 2,138,658 shares of the company's stock worth $119,743,000 after purchasing an additional 1,752,946 shares during the period. Norges Bank purchased a new stake in shares of Oklo in the fourth quarter worth about $73,786,000. Millennium Management LLC boosted its position in shares of Oklo by 4,974.1% in the first quarter. Millennium Management LLC now owns 582,002 shares of the company's stock valued at $12,589,000 after acquiring an additional 570,532 shares during the period. Van ECK Associates Corp boosted its position in shares of Oklo by 13.9% in the fourth quarter. Van ECK Associates Corp now owns 3,956,281 shares of the company's stock valued at $283,902,000 after acquiring an additional 481,288 shares during the period. Finally, Bank of New York Mellon Corp purchased a new position in Oklo during the second quarter valued at approximately $24,532,000. Institutional investors own 85.03% of the company's stock.

About Oklo

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source